Cited by 488Alzheimer's disease research and treatmentsSignaling Pathways in DiseaseNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production

Pastorino, Lucia, Sun, Anyang, Lu, Pei-Jung, Zhou, Xiao Zhen, Balastik, Martin, Finn, Greg, Wulf, Gerburg, Lim, Jormay, Li, Shi-Hua, Li, Xiaojiang, Xia, Weiming, Nicholson, Linda K., Lu, Kun Ping·2006·Nature

DOI 10.1038/nature04543

Open this paper in CoChat — free account

Abstract

Neuropathological hallmarks of Alzheimer's disease are neurofibrillary tangles composed of tau and neuritic plaques comprising amyloid-beta peptides (Abeta) derived from amyloid precursor protein (APP), but their exact relationship remains elusive. Phosphorylation of tau and APP on certain serine or threonine residues preceding proline affects tangle formation and Abeta production in vitro. Phosphorylated Ser/Thr-Pro motifs in peptides can exist in cis or trans conformations, the conversion of which is catalysed by the Pin1 prolyl isomerase. Pin1 has been proposed to regulate protein function by accelerating conformational changes, but such activity has never been visualized and the biological and pathological significance of Pin1 substrate conformations is unknown. Notably, Pin1 is downregulated and/or inhibited by oxidation in Alzheimer's disease neurons, Pin1 knockout causes tauopathy and neurodegeneration, and Pin1 promoter polymorphisms appear to associate with reduced Pin1 levels and increased risk for late-onset Alzheimer's disease. However, the role of Pin1 in APP processing and Abeta production is unknown. Here we show that Pin1 has profound effects on APP processing and Abeta production. We find that Pin1 binds to the phosphorylated Thr 668-Pro motif in APP and accelerates its isomerization by over 1,000-fold, regulating the APP intracellular domain between two conformations, as visualized by NMR. Whereas Pin1 overexpression reduces Abeta secretion from cell cultures, knockout of Pin1 increases its secretion. Pin1 knockout alone or in combination with overexpression of mutant APP in mice increases amyloidogenic APP processing and selectively elevates insoluble Abeta42 (a major toxic species) in brains in an age-dependent manner, with Abeta42 being prominently localized to multivesicular bodies of neurons, as shown in Alzheimer's disease before plaque pathology. Thus, Pin1-catalysed prolyl isomerization is a novel mechanism to regulate APP processing and Abeta production, and its deregulation may link both tangle and plaque pathologies. These findings provide new insight into the pathogenesis and treatment of Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1038/nature04543

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Principles of Nuclear Magnetic Resonance in One and Two Dimensions
Ernst, R. R., Bodenhausen, G., Wokaun, A. J., & Redfield, A. G. (1989) · Physics Today · doi:10.1063/1.2811094 · Cited by 4,202
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Neurodegenerative Tauopathies
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Self-citation
Principles of nuclear magnetic resonance in one and two dimensions
Redpath, T. W. (1988) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(88)90413-4 · Cited by 1,208

Flagged first, then by citations

Show all 32 references

Sorted by citations

Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
Self-citation
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Prolyl cis-trans isomerization as a molecular timer
Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 655
Self-citation
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 683
Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling
Matsuzawa, A., & Ichijo, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.011 · Cited by 507
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., et al. (2015) · Nature · doi:10.1038/nature14658 · Cited by 445
Self-citation
The amyloid precursor protein: beyond amyloid.
Zheng, H., & Koo, E. H. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-5 · Cited by 423
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
Elevation of glutathione as a therapeutic strategy in Alzheimer disease
Pocernich, C. B., & Butterfield, D. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.003 · Cited by 351
Biology and pathophysiology of the amyloid precursor protein
Zheng, H., & Koo, E. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-27 · Cited by 374
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor
Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 348
Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69003 · Cited by 322
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1222 · Cited by 336
Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins
Liou, Y., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 333
Self-citation
Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis
Small, S. A., & Gandy, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.001 · Cited by 328
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set
Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 275
Self-citation
Substrate specificity of γ-secretase and other intramembrane proteases
Beel, A. J., & Sanders, C. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7462-2 · Cited by 274
PIN1, the cell cycle and cancer
Yeh, E. S., & Means, A. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2107 · Cited by 268
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Nakamura, K., Greenwood, A., Binder, L. I., Bigio, E. H., Denial, S., Nicholson, L. K., Zhou, X. Z., & Lu, K. P. (2012) · Cell · doi:10.1016/j.cell.2012.02.016 · Cited by 260
Self-citation
Cellular Functions of the Amyloid Precursor Protein from Development to Dementia
van der Kant, R., & Goldstein, L. S. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.022 · Cited by 270
The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease
Müller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.05.002 · Cited by 261
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Yoon, S. O., Park, D. J., Ryu, J. C., Özer, H. G., Tep, C., Shin, Y. J., Lim, T. H., Pastorino, L., Kunwar, A. J., Walton, J. C., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.024 · Cited by 243
Self-citation
Dual‐specificity tyrosine(Y)‐phosphorylation regulated kinase 1A‐mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease
Ryoo, S., Cho, H., Lee, H. W., Jeong, H. K., Radnaabazar, C., Kim, Y., Kim, M., Son, M., Seo, H., Chung, S., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05075.x · Cited by 238
Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome
Rukhsana Sultana, A., Debra Boyd-kimball, A., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., & Butterfield, D. A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11203 · Cited by 230
Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells
Sutinen, E. M., Pirttilä, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-199 · Cited by 232
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214
Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy
Picone, P., Nuzzo, D., Caruana, L., Scafidi, V., & Carlo, M. D. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/780179 · Cited by 219
Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Fein, J. A., Sokolow, S., Miller, C. A., Vinters, H. V., Yang, F., Cole, G. M., & Gylys, K. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070829 · Cited by 218
Prolyl isomerase Pin1 in cancer
Lu, Z., & Hunter, T. R. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 205
Multivesicular bodies in neurons: Distribution, protein content, and trafficking functions
von Bartheld, C. S., & Altick, A. L. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.003 · Cited by 207
Tau local structure shields an amyloid-forming motif and controls aggregation propensity
Chen, D., Drombosky, K. W., Hou, Z., Sari, L., Kashmer, O. M., Ryder, B. D., Perez, V. A., Woodard, D. R., Lin, M. M., Diamond, M. I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10355-1 · Cited by 188
Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts
Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 202
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193
Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis
Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215
Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular Function
Lee, T. H., Chen, C.-H., Suizu, F., Huang, P., Schiene-Fischer, C., Daum, S., Zhang, Y. J., Goate, A., Chen, R.-H., Zhou, X. Z., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.005 · Cited by 183
Self-citation
A Common Biological Mechanism in Cancer and Alzheimers Disease?
Behrens, M. I., Lendon, C., & Roe, C. M. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 186
Proline cis-trans Isomerization Controls Autoinhibition of a Signaling Protein
Sarkar, P., Reichman, C., Saleh, T., Birge, R. B., & Kalodimos, C. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.004 · Cited by 189
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181
Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Lee, T. H., Pastorino, L., & Lu, K. P. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001906 · Cited by 185
Self-citation
REVIEW: Pin1 in Alzheimer's disease
Butterfield, D. A., Abdul, H. M., Opii, W. O., Newman, S. F., Gururaj Joshi, A., Ansari, M. A., & Rukhsana Sultana, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03995.x · Cited by 182
Structural Studies of the Transmembrane C-Terminal Domain of the Amyloid Precursor Protein (APP): Does APP Function as a Cholesterol Sensor?
Beel, A. J., Mobley, C. K., Kim, H. J., Tian, F., Hadziselimovic, A., Jap, B. K., Prestegard, J. H., & Sanders, C. R. (2008) · Biochemistry · doi:10.1021/bi800993c · Cited by 182
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., & Eisel, U. L. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0976 · Cited by 178
A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis
Andrew, R. J., Kellett, K. A. B., Thinakaran, G., & Hooper, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.746032 · Cited by 186
The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer
Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P. G., Rosato, A., Kaplan, F. M., Capobianco, A. J., Pece, S., Fiore, P. P. D., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1822 · Cited by 170
The emerging role of glutathione in Alzheimer’s disease
Saharan, S., & Mandal, P. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132483 · Cited by 168
Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid–Alzheimer's disease relationships?
Beel, A. J., Sakakura, M., Barrett, P. J., & Sanders, C. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.008 · Cited by 170
Cholinergic‐associated loss of hnRNP‐A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice
Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D., Ketzef, M., Becker, A. J., Friedman, A., & Soreq, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100995 · Cited by 166
Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes
Prete, D. D., Suski, J. M., Oulès, B., Debayle, D., Gay, A.-S., Lacas‐Gervais, S., Bussiere, R., Bauer, C., Pinton, P., Paterlini-Bréchot, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160953 · Cited by 167
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Chen, Y., Wu, Y., Yang, H., Li, X., Jie, M., Hu, C.-J., Wu, Y., Yang, S., & Yang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0844-y · Cited by 165
Self-citation
Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae
Albayram, Ö., Kondo, A., Mannix, R., Smith, C., Tsai, C.-Y., Li, C., Herbert, M. K., Qiu, J., Monuteaux, M. C., Driver, J. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01068-4 · Cited by 154
Self-citation
Co‐ and Post‐Translational Protein Folding in the ER
Ellgaard, L., McCaul, N., Chatsisvili, A., & Braakman, I. (2016) · Traffic · doi:10.1111/tra.12392 · Cited by 154
Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors
Jacobsen, K. T., & Iverfeldt, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0020-8 · Cited by 139
Pin1 Interacts With a Specific Serine-Proline Motif of Hepatitis B Virus X-Protein to Enhance Hepatocarcinogenesis
Pang, R. W. C., Lee, T. K., Poon, R. T. P., Fan, S. T., Wong, K., Kwong, Y., & Tse, E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.12.030 · Cited by 134
Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways
Lanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130
Critical Role of the Proline-rich Region in Huntingtin for Aggregation and Cytotoxicity in Yeast
Dehay, B., & Bertolotti, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605558200 · Cited by 136
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126
Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease
Lloret, A., Fuchsberger, T., Giraldo, E., & Viña, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.028 · Cited by 135
Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder
Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126
Regulation of Amyloid β-Protein Precursor by Phosphorylation and Protein Interactions
Suzuki, T., & Nakaya, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800003200 · Cited by 122
The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease
Blair, L. J., Baker, J. D., Sabbagh, J. J., & Dickey, C. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13033 · Cited by 120
Peptidyl-prolyl isomerization targets rice Aux/IAAs for proteasomal degradation during auxin signalling
Jing, H., Yang, X., Zhang, J., Liu, X., Zheng, H., Dong, G., Nian, J., Feng, J., Xia, B., Qian, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms8395 · Cited by 121
Endosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases
Bronfman, F. C., Escudero, C. A., Weis, J., & Krüttgen, A. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20513 · Cited by 121
Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies
Brillante, S., Volpe, M., & Indrieri, A. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.113 · Cited by 128
Tau Phosphorylation by GSK3 in Different Conditions
Ávila, J., León‐Espinosa, G., García, E., García‐Escudero, V., Hernández, F., & DeFelipe, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/578373 · Cited by 119
Disease modifying therapy for AD?1
Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117
Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives
Tseng, C.-H., Chen, Y., Lu, P., Yang, C.-N., & TZENG, C. ‐. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.028 · Cited by 116
Self-citation
Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy
Lim, J., Balaštík, M., Lee, T. H., Nakamura, K., Liou, Y., Sun, A., Finn, G., Pastorino, L., Lee, V. M. ‐., & Lu, K. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34308 · Cited by 117
Self-citation
Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance
Lee, T. H., Tun-Kyi, A., Shi, R., Lim, J., Soohoo, C., Finn, G., Balaštík, M., Pastorino, L., Wulf, G. M., Zhou, X. Z., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1818 · Cited by 114
Self-citation
Death‐associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes
Farag, A. K., & Roh, E. J. (2018) · Medicinal Research Reviews · doi:10.1002/med.21518 · Cited by 119
Phosphorylation Signaling in APP Processing in Alzheimer’s Disease
Zhang, T., Chen, D., & Lee, T. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010209 · Cited by 114
Altered lipid metabolism in a Drosophila model of Friedreich's ataxia
Navarro, J. A., Ohmann, E., Sánchez, D., Botella, J., Liebisch, G., Moltó, M. D., Ganfornina, M. D., Schmitz, G., & Schneuwly, S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq183 · Cited by 114
Amyloid precursor protein and amyloid precursor-like protein 2 in cancer
Pandey, P., Sliker, B. H., Peters, H. L., Tuli, A., Herskovitz, J., Smits, K., Purohit, A., Singh, R. K., Dong, J., Batra, S. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7103 · Cited by 109
Molecular crosstalk between cancer and neurodegenerative diseases
Seo, J., & Park, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03428-3 · Cited by 109
Protein aggregation as a paradigm of aging
Lindner, A. B., & Démarez, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.005 · Cited by 111
Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Essential Role of Proline Isomerization in Stefin B Tetramer Formation
Kokalj, S. J., Gunčar, G., Štern, I., Morgan, G. J., Rabzelj, S., Kenig, M., Staniforth, R. A., Waltho, J. P., Žerovnik, E., & Türk, V. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.12.025 · Cited by 109
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
Moore, J. D., & Potter, A. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.088 · Cited by 105
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila
Muffat, J., Walker, D. W., & Benzer, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800896105 · Cited by 112
Post‐phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function
Zita, M. M., Marchionni, I., Bottos, E., Righi, M., Sal, G. D., Cherubini, E., & Zacchi, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601625 · Cited by 103
The interactome of the amyloid β precursor protein family members is shaped by phosphorylation of their intracellular domains
Tamayev, R., Zhou, D., & D'adamio, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-28 · Cited by 111
Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function
Kim, B. M., You, M.-H., Chen, C.-H., Lee, S., Hong, Y., Hong, Y., Kimchi, A., Zhou, X. Z., & Lee, T. H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.216 · Cited by 98
Self-citation
Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease
Chen, C.-H., Li, W., Rukhsana Sultana, A., You, M., Kondo, A., Shahpasand, K., Kim, B. M., Luo, M.-L., Nechama, M., Lin, Y., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.027 · Cited by 95
Self-citation
Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer’s Disease
Mittal, K., Mani, R. J., & Katare, D. P. (2016) · Scientific Reports · doi:10.1038/srep25589 · Cited by 101
The emerging roles of protein homeostasis‐governing pathways in Alzheimer's disease
Cheng, J., North, B. J., Zhang, T., Dai, X., Tao, K., Guo, J., & Wei, W. (2018) · Aging Cell · doi:10.1111/acel.12801 · Cited by 102
De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system
Bosveld, F., Rana, A. K., van der Wouden, P. E., Lemstra, W., Ritsema, M., Kampinga, H. H., & Sibon, O. C. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn105 · Cited by 94
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 93
Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration
Борисович, Б. И., & Hiesinger, P. R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-23 · Cited by 89
Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism?
Balaštík, M., Lim, J., Pastorino, L., & Lu, K. P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.01.006 · Cited by 90
Self-citation
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer’s disease
Takahashi, K., Uchida, C., Shin, R.-W., Shimazaki, K., & Uchida, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7270-0 · Cited by 105
Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment
Huang, Q., Aluise, C. D., Gururaj Joshi, A., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22422 · Cited by 89
Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 95
Self-citation
Structural basis for regulation of the Crk signaling protein by a proline switch
Sarkar, P., Saleh, T., Tzeng, S., Birge, R. B., & Kalodimos, C. G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.494 · Cited by 87
Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65‐PTB2
Radzimanowski, J., Simon, B., Sattler, M., Beyreuther, K. T., Sinning, I., & Wild, K. (2008) · EMBO Reports · doi:10.1038/embor.2008.188 · Cited by 88
Small things matter: implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer’s disease.
Bukhari, H., Glotzbach, A., Kolbe, K., Leonhardt, G., Loosse, C., & Müller, T. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.005 · Cited by 88

Authors: Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., Xia, W., Nicholson, L. K., & Lu, K. P.
Affiliations: Beth Israel Deaconess Medical Center (US)
Kaohsiung Veterans General Hospital (TW)
Emory University (US)
Brigham and Women's Hospital (US)
Cornell University (US)
Corresponding author: Lu, Kun Ping
ORCID: Sun, Anyang
Lu, Pei-Jung
Zhou, Xiao Zhen
Wulf, Gerburg
Lim, Jormay
Li, Xiaojiang
Xia, Weiming
Nicholson, Linda K.
Lu, Kun Ping
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-03-23
Volume: 440
Issue: 7083
Pages: 528-534
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04543
OpenAlex: W1974036368
Cited by: 487
References: 32
Citations by year: 2026: 5 · 2025: 6 · 2024: 30 · 2023: 16 · 2022: 15 · 2021: 11 · 2020: 21 · 2019: 23 · 2018: 23 · 2017: 18 · 2016: 28 · 2015: 27 · 2014: 26 · 2013: 31 · 2012: 34
FWCI: 23.70
Type: journal article
Language: en
Update notices: erratum (2007-03-15)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Science Foundation
National Science Council
National Institutes of Health
National Institute on Aging (R01AG029385)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: peptidyl-prolyl isomerase, amyloid precursor protein, amyloid-beta production, Alzheimer's disease, cis-trans isomerization, APP phosphorylation, APP intracellular domain, tauopathy, neurofibrillary tangles, neuritic plaques, therapeutic target
MeSH terms: NIMA-Interacting Peptidylprolyl Isomerase, Alzheimer Disease, Animals, Catalysis, Cell Line, Cricetulus, Cricetinae, Humans, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Threonine, Transfection, Amyloid beta-Peptides, CHO Cells, Amyloid beta-Protein Precursor, Protein Structure, Tertiary, Mice, Knockout, Peptidylprolyl Isomerase, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks